摘要
目的:探讨小剂量溶栓药静脉溶栓及补救介入性治疗ST段抬高性心肌梗死(STelevatedmyocardialinfarction,STEMI)患者的安全性及疗效。方法:104例STEMI患者,按入组顺序并征得患者知情同意后分为两组,62例接受直接经皮冠状动脉介入治疗(percutaneouscoronaryintervention,PCI,指冠状动脉成形术)为PCI组,另42例为溶栓后补救性PCI组,先行小剂量组织型纤维蛋白溶酶原激活剂静脉溶栓,随后行冠状动脉造影,心肌梗死溶栓试验低于2级血流者行补救性PCI。比较两组的梗死相关动脉(infarctrelatedartery,IRA)开通率、左心室射血分数、ST段回落率、主要不良心脏事件。结果:与直接PCI组比较,溶栓后补救性PCI组具有较高的左心室射血分数(0.56±0.08比0.61±0.10,P<0.01)和ST段回落率(81%比95%,P<0.05),IRA开通率和主要不良心脏事件两组比较差异无统计学意义(均为P>0.05)。溶栓后补救性PCI组出血发生率无增加。结论:小剂量溶栓药静脉溶栓及补救性介入治疗是ST段抬高性AMI获得早期持续再灌注安全而有效的方法。
Objective: To study the safety and efficacy of rescue angioplasty following low-dose thrombolytic therapy in acute myocardial infarction(AMI). Methods: Sixty-two patients with ST elevated myocardial infarction (STEMI) were treated with direct percutaneous coronary intervention (PCI), and 42 patients with STEMT were treated with rescue angioplasty following low-dose thrombolytic therapy. The left ventricular ejection fraction (LVEF), ST-segment decline rate, reperfusion rate and major adverse cardiac event (MACE) rate were compared between the two groups. Results: The LVEF and ST-segment decline rate in the rescue angioplasty group were significantly higher than those in PCI group (0. 56 ±0. 08 vs 0. 61 ±0. 10, P 〈0. 01, 81% vs 95%, P 〈0. 05). The reperfusion rate and MACE rate had no differences between the two groups (P 〉 0. 05). No serious bleeding occurred in the rescue angioplasty group. Conclusion: The rescue angioplasty following low-dose thrombolytic therapy is safe and efficient.
出处
《新医学》
北大核心
2005年第11期639-641,共3页
Journal of New Medicine